#biotech-innovation

[ follow ]
fromwww.theguardian.com
3 days ago

Can scientists really resurrect the dodo? Inside the company that says they can

Colossal Biosciences, valued at $10.2bn after raising hundreds of millions of dollars in funding from investors including celebrities spanning from Tiger Woods to Paris Hilton, has provoked a stampede of acclaim as well as denunciation after announcing last year it had made the dire wolf, a species lost from the world for more than 10,000 years, de-extinct via the birth of three new pups.
OMG science
fromBoston.com
1 week ago

New 'call a boomer' phone line connects young people in Boston to seniors in Nevada

Younger adults and older adults tend to experience the highest levels of loneliness of any age group, so the goal of this project is to inspire generational connection through meaningful conversations, despite differences in age, lifestyle, or politics.
Boston
Venture
fromTNW | Investors-Funding
1 week ago

Breakout Ventures closes $114m Fund III

Breakout Ventures closed its third $114 million fund, focusing on AI applications in biology to accelerate drug discovery, diagnostics, and neurotechnology rather than general AI tools.
OMG science
fromFuturism
2 weeks ago

Researchers Get Human Brain Cells Running Doom

Cortical Labs taught living human brain cells to play the complex 3D video game Doom, advancing biological computing capabilities beyond their previous Pong achievement.
Startup companies
fromBoston.com
2 weeks ago

Two Boston startups join the race to create the next major weight-loss drug

Boston startups Vivtex and Nimbus Therapeutics partner with major pharmaceutical companies to develop next-generation oral obesity treatments using advanced drug delivery and AI technologies.
fromIPWatchdog.com | Patents & Intellectual Property Law
4 months ago

The WIPO Treaty on Genetic Resources: A Misguided Expansion That Threatens the Patent Bargain

Increasingly, patents have become proxies for achieving unrelated policy objectives-from reducing drug prices to constraining certain industries. The WIPO Treaty continues this trend by burdening the patent system with social and political aims that fall outside its purpose. The likely outcome is weakened protection for biotechnology and pharmaceutical innovation, especially for discoveries derived from genetic resources or traditional knowledge. The result would be less research investment and slower progress in precisely those areas where humanity benefits most-healthcare, sustainability, and food security.
Intellectual property law
[ Load more ]